# Outcome in Patients Treated with Intraarterial Thrombectomy - OptiMAL Blood Pressure Control (OPTIMAL-BP)

Study · id `cardio:ct-nct04205305` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04205305](<https://clinicaltrials.gov/study/NCT04205305>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04205305

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: High blood pressure; Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 306 participants.

## Technical summary

Registry record NCT04205305. Randomized; single masking; primary purpose treatment. Start 2020-06-18 (actual); primary completion 2023-07-23 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 306 participants (enrolled count; ClinicalTrials.gov record NCT04205305, source copy `cardio:ctgov-nct04205305-2025-03-19`, retrieved 2026-10-26)
- Started: 2020-06-18 (actual) (ClinicalTrials.gov record NCT04205305, source copy `cardio:ctgov-nct04205305-2025-03-19`, retrieved 2026-10-26)
- Primary completion: 2023-07-23 (actual) (ClinicalTrials.gov record NCT04205305, source copy `cardio:ctgov-nct04205305-2025-03-19`, retrieved 2026-10-26)
- Completion: 2023-07-23 (actual) (ClinicalTrials.gov record NCT04205305, source copy `cardio:ctgov-nct04205305-2025-03-19`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT04205305, source copy `cardio:ctgov-nct04205305-2025-03-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04205305-2025-03-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Outcome in Patients Treated with Intraarterial Thrombectomy - OptiMAL Blood Pressure Control (OPTIMAL-BP)
- Condition: Ischemic Stroke
- Intervention (Drug): conventional blood pressure control (labetalol, nicardipine)
- Intervention (Drug): intensive blood pressure control (labetalol, nicardipine)
- Lead sponsor: Yonsei University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Yonsei University (`cardio:org-yonsei-university`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Intensive vs Conventional Blood Pressure Lowering After Endovascular Thrombectomy in Acute Ischemic Stroke: The OPTIMAL-BP Randomized Clinical Trial (`cardio:pubmed-37668619`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of blood pressure lowering in patients treated with intravenous thrombolysis before endovascular thrombectomy (`cardio:pubmed-39819210`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Association Between Intravenous Antihypertensives and Functional Outcome After Successful Endovascular Thrombectomy (`cardio:pubmed-40605757`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Blood pressure management based on infarct volume after successful endovascular thrombectomy (`cardio:pubmed-40317165`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Poorer Outcomes With Blood Pressure Lowering in Severe White Matter Disease After Thrombectomy (`cardio:pubmed-41744094`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Intensive Versus Conventional Blood Pressure Lowering After Successful Endovascular Thrombectomy: OPTIMAL-BP 1-Year Outcomes (`cardio:pubmed-42212393`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Acute Kidney Injury After Intensive Blood Pressure Lowering Following Successful Endovascular Thrombectomy (`cardio:pubmed-42495732`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0da1c05b7a87f83c80d8e52daac85bdb14197e725527018d37c95019fbf82460
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
